These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39102178)

  • 1. Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study.
    D'Arcangelo F; Zanetto A; Ferrarese A; Gambato M; Lanari J; Piano S; Germani G; Senzolo M; Russo FP; Angeli P; Cillo U; Burra P
    Updates Surg; 2024 Sep; 76(5):1807-1818. PubMed ID: 39102178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Functional Frailty and Radiographic Sarcopenia as Predictors of Outcomes After Liver Transplant.
    Olson SL; Polineni P; Schwartz WAH; Thuluvath AJ; Duarte-Rojo A; Ladner DP
    Clin Transplant; 2024 Jul; 38(7):e15412. PubMed ID: 39049617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list.
    Perdiguero GG; Spina JC; Martínez J; Savluk L; Saidman J; Bonifacio M; Bakken S; Padilla M; Gallego-Clemente E; Moreno-González V; De Santibañes M; Marciano S; De Santibañes E; Gadano A; Pekolj J; Abraldes JG; Mauro E
    JHEP Rep; 2024 Mar; 6(3):100985. PubMed ID: 38384670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in the Association Between Frailty and Sarcopenia in Patients With Cirrhosis.
    Fozouni L; Wang CW; Lai JC
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00102. PubMed ID: 31789932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
    Lu D; Hu Z; Chen H; Khan AA; Xu Q; Lin Z; Li H; Zhuo J; He C; Zhuang L; Yang Z; Dong S; Cai J; Zheng S; Xu X
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):2071-2083. PubMed ID: 39192518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
    Tandon P; Ney M; Irwin I; Ma MM; Gramlich L; Bain VG; Esfandiari N; Baracos V; Montano-Loza AJ; Myers RP
    Liver Transpl; 2012 Oct; 18(10):1209-16. PubMed ID: 22740290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
    J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
    Lai JC; Ganger DR; Volk ML; Dodge JL; Dunn MA; Duarte-Rojo A; Kappus MR; Rahimi RS; Ladner DP; Boyarsky B; McAdams-DeMarco M; Segev DL; McCulloch CE; Verna EC
    JAMA Surg; 2021 Mar; 156(3):256-262. PubMed ID: 33377947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis.
    Cullaro G; Verna EC; Duarte-Rojo A; Kappus MR; Ganger DR; Rahimi RS; Boyarsky B; Segev DL; McAdams-DeMarco M; Ladner DP; Volk ML; Hsu CY; Lai JC
    Hepatol Commun; 2022 Apr; 6(4):910-919. PubMed ID: 34676697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
    Pascasio JM; Vinaixa C; Ferrer MT; Colmenero J; Rubin A; Castells L; Manzano ML; Lorente S; Testillano M; Xiol X; Molina E; González-Diéguez L; Otón E; Pascual S; Santos B; Herrero JI; Salcedo M; Montero JL; Sánchez-Antolín G; Narváez I; Nogueras F; Giráldez Á; Prieto M; Forns X; Londoño MC
    J Hepatol; 2017 Dec; 67(6):1168-1176. PubMed ID: 28842296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized measures of frailty predict hospital length of stay following orthotopic liver transplantation for hepatocellular carcinoma.
    DeMaria S; Khromava M; Schiano TD; Lin HM; Kim S
    Clin Transplant; 2019 Dec; 33(12):e13746. PubMed ID: 31664734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and plasma protein biomarkers associated with frailty in patients with cirrhosis.
    Ha NB; Seetharaman S; Kent DS; Yao F; Shui AM; Huang CY; Walston J; Lai JC
    Liver Transpl; 2023 Oct; 29(10):1089-1099. PubMed ID: 36932707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waiting time dictates impact of frailty: A Spanish multicenter prospective study.
    Puchades L; Herreras J; Ibañez A; Reyes É; Crespo G; Rodríguez-Perálvarez M; Cortés L; Serrano T; Fernández-Yunquera A; Montalvá E; Berenguer M
    JHEP Rep; 2023 Nov; 5(11):100840. PubMed ID: 37767462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study.
    van Vugt JLA; Buettner S; Alferink LJM; Bossche N; de Bruin RWF; Darwish Murad S; Polak WG; Metselaar HJ; IJzermans JNM
    Transpl Int; 2018 Feb; 31(2):165-174. PubMed ID: 28871624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
    Lai JC; Dodge JL; Kappus MR; Dunn MA; Volk ML; Duarte-Rojo A; Ganger DR; Rahimi RS; McCulloch CE; Haugen CE; McAdams-DeMarco M; Ladner DP; Segev DL; Verna EC;
    J Hepatol; 2020 Sep; 73(3):575-581. PubMed ID: 32240717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.